Today, we get our first look at IGI: Origins, the first new title in the IGI series in well over a decade. You may remember IGI: Origins from a modest reveal from earlier in the year. This is indeed ...
Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) cells ISB 2301 is rapidly advancing toward the clinic; ...
NEW YORK and NORTH CHICAGO, Ill., July 10, 2025 /PRNewswire/ -- IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (NYSE: ABBV) today ...
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Ichnos Glenmark Innovation (IGI), an alliance between Ichnos Sciences Inc., a global fully integrated clinical-stage biotech company developing ...
Mehrdad (He/Him) is a Senior Staff Writer from Iran. He started writing about video games when he was a high-school student. He loves playing competitive FPS games such as Rainbow Six Siege and ...
Mehrdad (He/Him) is a Senior Staff Writer from Iran. He started writing about video games when he was a high-school student. He loves playing competitive FPS games such as Rainbow Six Siege and ...
NEW YORK and NORTH CHICAGO, Ill., July 10, 2025 (GLOBE NEWSWIRE) -- IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (NYSE: ABBV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results